The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Illumina Inc  (ILMN) Trade Now »     Rate ILMN  -  Discuss ILMN  -  Add to Watch List         Graphic_subscribe

       Sector: Technology  >  Industry: Scientific & Technical Instr.
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
98.5%
Top:
100.0%
Rate ILMN:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

ILMN: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

The Trend Trendy Enough to Get In Graphic_rating_buy ILMN
Dcgicon
50%
 -11.62%
in 22 days
(closed on 09/05/08)

This is one of the only charts I have ever seen with an almost  perfectly straight trend.

This is an atypical trade for me, as I am primarily a contrarian trader but this seems to have an singular purity which I havent seen elsewhere.

By  David Caro-Greene   (-4.50%  risk: moderate)  08/14/08 Comment


Illumina Inc Graphic_rating_buy ILMN <> ...
Foto
62%
 -34.46%
in 500 days
Analysts'
 Recommendation: 		Strong Buy  
    30 Days Ago: Strong Buy  
  Analysts' Target: $100  
<> <>
Analysts' Targets
 UBS Securities $110 
By  Marian Filo   (-24.55%  risk: aggressive)  07/13/08 Comment


Who needs "C" research?!? Graphic_rating_buy ILMN
Heavey_turkey_open
11%
 -27.77%
in 575 days
Answer: "C" will touch every family in some form or another.  The tremendous discovery may lie in human genome sequencing.  no magic bullet.....just STRONG PREVENTATIVE MEDICINE!
By  Catfish31015   (-15.90%  risk: moderate)  04/29/08 Comment


ILMN has a decent tone in early trading so keep it on the radar ILMN
+36.60%
in 1036 days
Illumina, Inc. has a decent tone in early trading so keep it on the radar. This stock has an improving chart.
By  knighttrader   (-19.99%  risk: aggressive)  01/24/07 Comment






From the Blogosphere

Notable Analyst Rating Changes 10/28: TXN, MOT, TGT, WYNN, ILMN Upgraded; APOL, SNDK, NVDA, X, VCLK Downgraded
UPGRADES:Goldman Sachs upgrades Texas Instruments Inc. (NYSE: TXN) from Neutral to BuyRBC Capital upgrades Motorola (NYSE: MOT) from Sector Perform to Outperform. Citigroup upgraded Target Corp (NYSE: TGT) from Sell to Buy and raised their price target from $44 to $61.Oppenheimer upgrades Wynn Resorts (NASDAQ: WYNN) from Market Perform to Outperform. The firm maintains a $73 price target.Caris & Co upgrades Illumina (NASDAQ: ILMN) from Average to Above Average. Price target increased to $42. For daily real-time Upgrades go to http://www.streetinsider.com/UpgradesDOWNGRADES:Bank of America d...
By  Street Insider   (+10.66%  risk: moderate)  10/28/09 Comment


Early Week Earnings Watch
Tradermark
34%
2nd of the 3 big weeks for S&P 500 type companies arrives; last week was an unqualified success of setting expectations low, cutting expenses aggressively and beating very slow to adjust analysts expectations. Now with the bar raised higher as expectations ramped up, I expect the sledding to be a bit tougher.

Here are names of interest in the early part of the week; with names the market will be watching and some additional ones that I like to look at. Tuesday will be the more interesting day. I forgot about earnings knee jerk reaction time, when I shorted American Express (AXP) and <>Capit...
By  Trader Mark   (-7.03%  risk: moderate)  07/20/09 Comment


Biotech stock #6: Illumina (ILMN) Graphic_rating_buy ILMN
-12.94%
in 137 days

Filed under: Stocks to Buy

biotech stocks illuminaDo you think we're going to see more or less genomics research in coming years? End of discussion.

Illumina (NASDAQ: ILMN) is the leading provider of equipment for genomics researchers and its lead is growing. Buy and hold may be almost dead, but it certainly applies to ILMN. The stock has been trashed along with the market, but it's simply the best at what it does - and getting better.

Your best strategy for life-changing profits?

<>This is a stock to buy for the long term to use as a base for selling calls. Or, even better, you can write some credit spreads, as the ca...
By  Michael Shulman   (-17.64%  risk: conservative)  07/12/09 Comment


6 bang-for-your-buck biotech stocks

Filed under: Gilead Sciences (GILD), Stocks to Buy

biotech stocksLast year, as the market sank, one group actually went up -- large-cap, cashflow positive biotech and genomics companies.

This year, interest has shifted to the little guys -- the speculative biotech stocks that could be 10- or 20-baggers with one breakthrough.

Here are six biotech stocks with the potential to deliver life-changing profits:

<>Biotech Stock #1: Gilead Sciences (NASDAQ: GILD)
Biotech Stock #2: Questcor Pharmaceuticals (NASDAQ: QCOR)
Biotech Stock #3: Cepheid (NASDAQ: CPHD)
Biotech Stock #4: Curis (NASDAQ: CRIS)
Biotech Stock #5: <>Cerus ...
By  Michael Shulman   (-17.64%  risk: conservative)  07/11/09 Comment


Bookkeeping: Closing Ilumina (ILMN) on Warning; Will Revisit Later in the Year
Tradermark
34%
I only have about a 0.4% stake in Illumina (ILMN) so I am going to take about a 8% loss on this last batch (stock is down about 10%) today on the earnings warning. The stock had just been flopping around listlessly so it was not a major position for us, thankfully.

A large gap has been created which is going to take time to work through and time is money. It's not exactly a "value buyers" dream down here either as it is still rich.... valuations like this are based on continued excellence in executation and ILMN's armor has been penetrated from that angle. The stock is down a lot less th...
By  Trader Mark   (-7.03%  risk: moderate)  07/02/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.37% 380
2 Gerald Greene 18.14 +70.70% 210
3 stockmarketfunding.com 17.66 +25.67% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +78.05% 39


POPULAR STOCKS
Symbol Company Name Sentiment
MSFT Microsoft Corp
GOOG Google Inc
KO The CocaCola Company
GLD streetTRACKS Gold
MA MasterCard Inc
GE General Electric Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on ILMN

Visit streetinsider.com


Discussion Wall + Add  
amritadas   (+0.00%)
A FREE report on upcoming FDA decision for small ca.. - FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the com...
+   0 replies


More Resources

Graphic_arrow1 About Illumina Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch